Skip to main content

Advertisement

Open Peer Review Reports for: Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Sep 2006 Submitted Original manuscript
2 Oct 2006 Reviewed Reviewer Report - Yoichi Mizutani
8 Oct 2006 Reviewed Reviewer Report - Axel Merseburger
17 Oct 2006 Reviewed Reviewer Report - Rodolfo Montironi
6 Nov 2006 Author responded Author comments - Giuseppe Pannone
Resubmission - Version 2
6 Nov 2006 Submitted Manuscript version 2
22 Nov 2006 Author responded Author comments - Giuseppe Pannone
Resubmission - Version 3
22 Nov 2006 Submitted Manuscript version 3
23 Nov 2006 Author responded Author comments - Giuseppe Pannone
Resubmission - Version 4
23 Nov 2006 Submitted Manuscript version 4
27 Nov 2006 Reviewed Reviewer Report - Yoichi Mizutani
28 Nov 2006 Reviewed Reviewer Report - Axel Merseburger
7 Dec 2006 Reviewed Reviewer Report - Rodolfo Montironi
11 Dec 2006 Author responded Author comments - Giuseppe Pannone
Resubmission - Version 5
11 Dec 2006 Submitted Manuscript version 5
17 Dec 2006 Author responded Author comments - Giuseppe Pannone
Resubmission - Version 6
17 Dec 2006 Submitted Manuscript version 6
Publishing
19 Dec 2006 Editorially accepted
19 Dec 2006 Article published 10.1186/1471-2407-6-293

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement